Biobanking: Economics and Impact
Conference Recording Jan 16, 2013
About the Speaker
Chana Rabiner received her PhD in Biomedical Science from the University of Connecticut Health Sciences Center in 2005 and was then awarded an NIH fellowship in the HHS Emerging Leaders Program. Chana joined NCI’s Office of Biorepositories and Biospecimen Research as one of its senior staff members in 2011.
While it is recognized that high quality biospecimens are critical in every aspect of today's medicine, the true cost and economic impact of biobanking has been poorly understood and better definition is needed. Current and future initiatives to address this will be discussed and evaluated. Topics will include: the total life cost of ownership, the costs associated with implementing best practices, how can the value of specimens and data be determined, and how can the economic benefits of biobanking be quantified.
Comments | 0 ADD COMMENT
EMBL Course: Transgenic Animals - Micromanipulation Techniques
Apr 10 - Apr 11, 2018
EMBO Practical Course: Extracellular Vesicles: From Biology to Biomedical Applications
Apr 09 - Apr 13, 2018
EMBO | EMBL Symposium: Tissue Self-Organisation: Challenging the Systems
Mar 11 - Mar 14, 2018
EMBL Course: Brillouin Microscopy: Emerging Tool for Probing Mechanical Properties of Living Cells
Jan 17 - Jan 19, 2018